Exact Mass: 369.0301322

C12H20ClN3O6S (369.07612900000004)

An organic heterotetracyclic compound that has formula C14H16BrN3O2S. It is a natural product isolated from the Caribbean tunicate Eudistoma olivaceum and exhibits potent anti-tumor and antiviral activities.

Triphenyltin hydroxide

Fentin hydroxide; Fentin

C18H17OSn (369.0301322)

S-(2-Chloroethyl)glutathione

lansoprazole

2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole

A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) > A02BC - Proton pump inhibitors C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29723 - Proton Pump Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents D004791 - Enzyme Inhibitors > D054328 - Proton Pump Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; EAWAG_UCHEM_ID 3137 Lansoprazole (AG 1749) is an orally active proton pump inhibitor which prevents the stomach from producing acid. Lansoprazole (AG 1749) is a potent brain penetrant neutral sphingomyelinase (N-SMase) inhibitor (exosome inhibitor)[1][2].

Lansoprazole

2-{[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methanesulfinyl}-1H-1,3-benzodiazole

C16H13Cl2NO5 (369.01707480000005)

Lansoprazole is a proton pump inhibitor similar to omeprazole which prevents the stomach from producing acid. Lansoprazoles plasma elimination half-life is not proportional to the duration of the drugs effects (i.e. gastric acid suppression). The plasma elimination half-life is 1.5 hours or less, and the effects of the drug last for over 24 hours after it has been given for 5 days or more. [HMDB] Lansoprazole is a proton pump inhibitor similar to omeprazole which prevents the stomach from producing acid. Lansoprazoles plasma elimination half-life is not proportional to the duration of the drugs effects (i.e. gastric acid suppression). The plasma elimination half-life is 1.5 hours or less, and the effects of the drug last for over 24 hours after it has been given for 5 days or more. A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) > A02BC - Proton pump inhibitors C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29723 - Proton Pump Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents D004791 - Enzyme Inhibitors > D054328 - Proton Pump Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Lansoprazole (AG 1749) is an orally active proton pump inhibitor which prevents the stomach from producing acid. Lansoprazole (AG 1749) is a potent brain penetrant neutral sphingomyelinase (N-SMase) inhibitor (exosome inhibitor)[1][2].

(-)-Epicatechin sulfate

(3R)-2-(3,4-Dihydroxyphenyl)-8-hydroxy-3-(sulphooxy)-3,4-dihydro-2H-1-benzopyran-6-olic acid

C15H13O9S- (369.0280268)

Epicatechin sulfate is the sulfate form of (-)-epicatechin at the o-3 position. (-)-epicatechin is an antioxidant flavonoid, occurring especially in woody plants as both (+)-catechin and (-)-epicatechin (cis) forms. Catechin is a tannin peculiar to green and white tea because the black tea oxidation process reduces catechins in black tea. Catechin is a powerful, water soluble polyphenol and antioxidant that is easily oxidized. Several thousand types are available in the plant world. As many as two thousand are known to have a flavon structure and are called flavonoids. Catechin is one of them. Green tea is manufactured from fresh, unfermented tea leaves; the oxidation of catechins is minimal, and hence they are able to serve as antioxidants. Researchers believe that catechin is effective because it easily sticks to proteins, blocking bacteria from adhering to cell walls and disrupting their ability to destroy them. Viruses have hooks on their surfaces and can attach to cell walls. The catechin in green tea prevents viruses from adhering and causing harm. Catechin reacts with toxins created by harmful bacteria (many of which belong to the protein family) and harmful metals such as lead, mercury, chrome, and cadmium. From its NMR espectra, there is a doubt on 2 and 3 atoms configuration. It seems to be that they are in trans position. Epicatechin sulfate in the urine is a biomarker for the consumption of legumes.

4'-Hydroxy Aceclofenac

2-[(2-{2-[(2,6-dichloro-4-hydroxyphenyl)amino]phenyl}acetyl)oxy]acetic acid

Thioflosulide

N-{6-[(2,4-difluorophenyl)sulphanyl]-1-oxo-2,3-dihydro-1H-inden-5-yl}methanesulphonamide

C16H13F2NO3S2 (369.0304892)

Purines

4-Pyridinol, 2-[[[5-(difluoromethoxy)-1H-benzimidazol-2-yl]sulfinyl]methyl]-3-methoxy-

C15H13F2N3O4S (369.05948020000005)

H 151/72

C16H13Cl2NO5 (369.01707480000005)

Ethyl 5-methyl-3-(methylthio)-4,4-dioxo-4,5-dihydro-4lambda6-benzo[c]thieno[3,4-e][1,2]thiazine-1-carboxylate

C15H15NO4S3 (369.016319)

(r,r)-7-amino-3-(1-methylpyrrolidinio)methyl-3-cephem-4-carboxylate hcl

C13H21Cl2N3O3S (369.0680616000001)

10-Methyl-9-phenylacridinium perchlorate

C20H16ClNO4 (369.07678060000006)

4-[(4-CHLORO-2,5-DIMETHYLPHENYL)SULFONYL!-3-NITROBENZOIC ACID

C15H12ClNO6S (369.00738420000005)

Sodium 5-O-(hydroxyphosphinato)adenosine

C10H13N5NaO7P (369.0450278)

(2-((4-FLUORO-3-(TRIFLUOROMETHYL)PHENYL)AMINO)-4-(PYRIDIN-4-YL)THIAZOL-5-YL)METHANOL

C16H11F4N3OS (369.05589240000006)

Robenidine hydrochloride

C15H14Cl3N5 (369.03147340000004)

D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent

N-BOC-BELTA-ALANINE-BELTA-4-BROMOPHENYL-N-CARBOXYANHYDRIDE

C15H16BrNO5 (369.02117860000004)

6-BROMO-2-(4-ISOPROPYLPHENYL)QUINOLINE-4-CARBOXYLICACID

C19H16BrNO2 (369.0364336)

2-Deoxyguanosine 3-monophosphate sodium salt

C10H13N5NaO7P (369.0450278)

9-(4-Iodophenyl)-9H-carbazole

C18H12IN (369.00144620000003)

5-Bromo-2-((trimethylsilyl)ethynyl)pyridin-3-yl tert-Butyl carbonate

C15H20BrNO3Si (369.03957500000007)

4-(4-bromophenyl)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-3-carboxylic acid

C16H20BrNO4 (369.0575620000001)

2,4-D-trolamine

C14H21Cl2NO6 (369.07458660000003)

Boc-trans-DL-b-Pro-4-(3-bromophenyl)-OH

C16H20BrNO4 (369.0575620000001)

Felodipine 3,5-Dimethyl Ester

C17H17Cl2NO4 (369.0534582000001)

Methyl 6-chloro-2-methyl-7-sulfamoyl-3,4-dihydro-2H-1,2,4-benzoth iadiazine-3-carboxylate 1,1-dioxide

C10H12ClN3O6S2 (368.98560419999995)

Dimethyl 4-(3,4-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyri dinedicarboxylate

C17H17Cl2NO4 (369.0534582000001)

sodium 4-[(4-chlorobenzoyl)(4-methoxyphenyl)amino]butyrate

C18H17ClNNaO4 (369.0743752000001)

(4R)-4-(ethylamino)-2-(3-hydroxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide-1,1-dioxide

C11H19N3O5S3 (369.0486804)

Disperse Yellow Se-Fl

C18H15N3O4S (369.07832300000007)

SDZ 220-581

C16H17ClNO5P (369.05328320000007)

SDZ 220-581 is an orally active, potent, competitive NMDA receptor antagonist with pKi value of 7.7[1].

Lansoprazole Sulfide N-Oxide

2-benzylamino-4-benzyloxy-5-bromopyrimidine

C18H16BrN3O (369.0476666)

SKF 81297 hydrobromide

C16H17BrClNO2 (369.0131112)

SKF 81297 hydrobromide is a potent and selective dopamine D1 receptor agonist[1].

3-iodo-9-phenylcarbazole

C18H12IN (369.00144620000003)

Bromodiphenhydramine hydrochloride

C20H20BrNO (369.07281700000004)

C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Bromodiphenhydramine hydrochloride is a potent antihistamine with antimicrobial property. Bromodiphenhydramine hydrochloride inhibits a large number of Gram negative and Gram positive bacteria. Bromodiphenhydramine hydrochloride can be used for cutaneous allergies research[1][2][3].

(5-Bromo-1-pentyl-1H-pyrrol-3-yl)(naphthalen-1-yl)methanone

Acetosulfone

N-[5-amino-2-(4-aminophenyl)sulfonyl-phenyl]sulfonylacetamide

C14H15N3O5S2 (369.04531)

C254 - Anti-Infective Agent > C849 - Sulfone Anti-Infective Agent

4-(2-bromophenyl)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-3-carboxylic acid

C16H20BrNO4 (369.0575620000001)

2-(1-(4-BROMOPHENYL)-3-OXOCYCLOBUTYL)ISOINDOLINE-1,3-DIONE

C18H12BrNO3 (369.00005020000003)

8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid

C19H13ClFN3O2 (369.068028)

6-bromo-8-cyclopentyl-2-methanesulfinyl-5-methyl-8H-pyrido[2,3-d]pyrimidin-7-one

(S)-Lansoprazole

C8H28Cl5N5 (369.07872380000003)

Tetraethylenepentamine Pentahydrochloride

(Z)-2-(2-aMinothiazol-4-yl)-2-(hydroxyiMino)-N-((5-Methyl-7-oxo-2,4,5,7-tetrahydro-1H-furo[3,4-d][1,3]thiazin-2-yl)Methyl)acetaMide

C13H15N5O4S2 (369.05654300000003)

N-[4-[[(4-chloro-3-nitrophenyl)sulphonyl]amino]phenyl]acetamide

C14H12ClN3O5S (369.01861720000005)

Tris(Cyclopentadienyl)Ytterbium(Iii)

C15H15Yb (369.056242)

(+/-)-4-HYDROXYDEBRISOQUIN

C16H17BrClNO2 (369.0131112)

5-Iodocytidine

C9H12IN3O5 (368.98216920000004)

TITANIUM(III) CHLORIDE TETRAHYDROFURAN COMPLEX

C12H24Cl3O3Ti (369.02704140000003)

Dexlansoprazole

C16H17Cl2N3OS (369.04693320000007)

A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) > A02BC - Proton pump inhibitors C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29723 - Proton Pump Inhibitor D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents D004791 - Enzyme Inhibitors > D054328 - Proton Pump Inhibitors (R)-Lansoprazole is the R enantiomer of Lansoprazole, Lansoprazole (AG 1749) is an orally active proton pump inhibitor which prevents the stomach from producing acid. Lansoprazole (AG 1749) is a potent brain penetrant neutral sphingomyelinase (N-SMase) inhibitor (exosome inhibitor)[1][2].

(r)-4-Ethylamino-3,4-dihydro-2-(2-methoylethyl)-2h-thieno[3,2-e]-1,2-thiazine-6-sulfonamide-1,1-dioxide

C11H19N3O5S3 (369.0486804)

N-({[4-(Aminosulfonyl)phenyl]amino}carbonyl)-4-methylbenzenesulfonamide

C14H15N3O5S2 (369.04531)

Bromo-WR99210

C14H20BrN5O2 (369.080028)

Thioflosulide

C16H13F2NO3S2 (369.0304892)

D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors

4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline

C19H16BrNO2 (369.0364336)

Cephalexin sodium

C16H16N3NaO4S (369.0759176)

N-(3-chloro-2-quinoxalinyl)-2-naphthalenesulfonamide

C18H12ClN3O2S (369.0338722)

4-[2-[(2,4-Dichlorophenyl)methylthio]-6-methyl-4-pyrimidinyl]morpholine

5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine

C18H13Cl2N5 (369.0547958)

Aredia

C3H19NNa2O12P2 (369.01778740000003)

C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates

2-((4-Bromophenyl)phenylmethoxy)ethyl(dimethyl)ammonium chloride

C17H11ClF3NO3 (369.03795220000006)

2-[4-(4-Chlorophenyl)-3-(trifluoromethyl)-1,2-oxazol-5-yl]-5-methoxyphenol

sodium;[(2S,3R,4R,5S)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate

C10H13N5NaO7P (369.0450278)

glutathione S-sulfinate(2-)

C10H15N3O8S2-2 (369.030055)

Toyocamycin phosphate

C12H12N5O7P-2 (369.0474332)

(3aR,4R,9bS)-4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline

C19H16BrNO2 (369.0364336)

N-[1-(benzenesulfonyl)-2,2-dichloroethenyl]-4-methylbenzamide

C16H13Cl2NO3S (368.9993168000001)

(E)-3-[5-(4-Acetyl-phenyl)-furan-2-yl]-2-(5-methyl-4H-[1,2,4]triazol-3-ylsulfanyl)-acrylic acid

C18H15N3O4S (369.07832300000007)

2-[[[1-(2-Methoxy-5-methylphenyl)-5-tetrazolyl]thio]methyl]-1,3-benzothiazole

C17H15N5OS2 (369.071798)

N-[3-[(4-chlorophenyl)methylthio]-1H-1,2,4-triazol-5-yl]-4-cyanobenzamide

C17H12ClN5OS (369.0451052)

N-{[3-(4-chlorophenyl)-1H-pyrazol-4-yl]methylene}-4-nitrobenzohydrazide

C17H12ClN5O3 (369.06286320000004)

2-[[4-(2-chlorophenyl)-5-sulfanylidene-1H-1,2,4-triazol-3-yl]methyl]-1-phthalazinone

C17H12ClN5OS (369.0451052)

3-(2-furyl)-N-({[4-(4-methylphenyl)-1,3-thiazol-2-yl]amino}carbonothioyl)acrylamide

C18H15N3O2S2 (369.060565)

2-Phenoxy-6-quinolinyl trifluoromethanesulfonate

C16H10F3NO4S (369.02826160000006)

5-Aminomethyl-2-thiouridine 5-monophosphate

C10H16N3O8PS (369.03957060000005)

(R)-beta-(p-bromobenzhydryloxy)ethyldimethylamine hydrochloride

N(2),3-etheno-cGMP

C12H12N5O7P (369.0474332)

(S)-beta-(p-bromobenzhydryloxy)ethyldimethylamine hydrochloride

[5-(2-amino-5-cyano-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl)-3-hydroxy-2,5-dihydrofuran-2-yl]methyl dihydrogen phosphate

C12H12N5O7P (369.0474332)

2’-Deoxy-N3-methylcytidine (hydriodide)

C10H16IN3O4 (369.0185526)

2’-Deoxy-N3-methylcytidine hydriodide is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

SMS2-IN-2

C19H13ClFN3O2 (369.068028)

SMS2-IN-2 is a potent, highly selective and orally active sphingomyelin synthase 2 (SMS2) inhibitor, with IC50s of 100 nM and 56 μM for SMS2 and SMS1, respectively. Anti-chronic inflammatory activity[1].

α-NETA

C16H20INO (369.058958)

α-NETA is a potent and noncompetitive choline acetyltransferase (ChA) inhibitor with an IC50 of 9 μM. α-NETA is a potent ALDH1A1 (IC50=0.04 μM) and chemokine-like receptor-1 (CMKLR1) antagonist. α-NETA weakly inhibits cholinesterase (ChE; IC50=84 μM) and acetylcholinesterase (AChE; IC50=300 μM). α-NETA has anti-cancer activity[1][2].

1-chloro-n-[(2s)-2-chloro-5-[(1r,3s)-3-chloro-2,2-dimethyl-6-methylidenecyclohexyl]-3-methylidenepentyl]methanecarbonimidoyl chloride

C16H23Cl4N (369.0584518)

(3r,4s,6s)-4-amino-15-bromo-8-oxa-6-thia-9,18-diazatetracyclo[9.7.0.0³,⁹.0¹²,¹⁷]octadeca-1(11),12,14,16-tetraen-6-ium-6-olate

1-chloro-n-{2-chloro-5-[(1r,3s)-3-chloro-2,2-dimethyl-6-methylidenecyclohexyl]-3-methylidenepentyl}methanecarbonimidoyl chloride

C16H23Cl4N (369.0584518)

2-amino-4-({2-[(2-amino-2-carboxyethyl)disulfanyl]-1-carboxyethyl}-c-hydroxycarbonimidoyl)butanoic acid

C11H19N3O7S2 (369.0664384)

(2s,3s,5s)-3-amino-15-bromo-7-oxa-5-thia-8,18-diazatetracyclo[9.7.0.0²,⁸.0¹²,¹⁷]octadeca-1(11),12,14,16-tetraen-5-ium-5-olate